To assess the clinical relevance of MLKs in glioma, we conducted an analysis examining the correlation between MLK expression levels and various clinical characteristics, including age, gender, World Health Organization (WHO) grades, and IDH mutation status (Tables S2 and S3). Here, MAP3K13 is linked to central nervous system cancer.